PADLOCK THERAPEUTICS INC has a total of 51 patent applications. It decreased the IP activity by 86.0%. Its first patent ever was published in 2016. It filed its patents most often in China, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are FANG WENKUI K, NEUROSCIENZE PHARMANESS S C A and BIOTIE THERAPIES GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Republic of Korea | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | United States | 4 | |
#6 | Argentina | 3 | |
#7 | Australia | 3 | |
#8 | Brazil | 3 | |
#9 | Canada | 3 | |
#10 | Israel | 3 | |
#11 | Mexico | 3 | |
#12 | Singapore | 3 | |
#13 | Taiwan | 3 | |
#14 | Uruguay | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Tye Heather | 43 |
#2 | Devraj Rajesh | 43 |
#3 | Kumaravel Gnanasambandam | 43 |
#4 | Lecci Cristina | 43 |
#5 | Gleave Laura | 33 |
#6 | Meniconi Mirco | 32 |
#7 | Monck Nat | 26 |
#8 | Palfrey Jordan | 22 |
#9 | Gadouleau Elise | 22 |
#10 | Kotey Adrian | 22 |
Publication | Filing date | Title |
---|---|---|
CN110248934A | Heteroaryl PAD4 inhibitor | |
EP3490989A1 | Covalent inhibitors of pad4 | |
EP3419969A1 | Heteroaryl inhibitors of pad4 | |
TW201726689A | Aza-benzimidazole inhibitors of PAD4 | |
AR107032A1 | PAD4 BICYCLIC INHIBITORS |